Search Results
Jul 07, 2026, 07:07 ET Healome Therapeutics Closes £2 Million Seed Round Led by Empirical Ventures to Advance Eye-Drop Matrix Technology for Ocular Surface Diseases
architectures, avoiding complex chemical modifications that can create manufacturing or regulatory issues.Rare disease application: Epidermolysis Bullosa (EB)EB is a rare genetic condition affecting approximately 500,000 people globally, of whom an estimated 5-20% experience ocular complications
More news about: Healome Therapeutics
Jul 07, 2026, 07:07 ET Healome Therapeutics Closes £2 Million Seed Round Led by Empirical Ventures to Advance Eye-Drop Matrix Technology for Ocular Surface Diseases
architectures, avoiding complex chemical modifications that can create manufacturing or regulatory issues.Rare disease application: Epidermolysis Bullosa (EB)EB is a rare genetic condition affecting approximately 500,000 people globally, of whom an estimated 5-20% experience ocular complications
More news about: Healome Therapeutics
Jul 07, 2026, 07:07 ET Healome Therapeutics clôture une levée de fonds d'amorçage de 2 millions de livres sterling menée par Empirical Ventures afin de faire progresser sa technologie de matrice de collyre destinée au traitement des maladies de la surface oculaire
problèmes de fabrication ou de conformité réglementaire.Utilisation dans le traitement d'une maladie rare : l'épidermolyse bulleuse (EB)L'EB est une maladie génétique rare qui touche environ 500 000 personnes dans le monde, dont 5 à 20 % environ souffrent de complications oculaires,
More news about: Healome Therapeutics
Jul 07, 2026, 06:00 ET Legionnaires' Disease Lawyers Investigate New York City Upper East Side Legionnaires' Disease Outbreak
systems can prevent Legionella bacteria from growing and spreading.About Legionnaires' DiseaseLegionnaires' disease is a rare type of pneumonia with symptoms like cough, shortness of breath, chills headaches, and muscle aches. Occasionally, symptoms such as diarrhea, nausea,
More news about: The Lange Law Firm
Jul 06, 2026, 20:00 ET Gravity Game Unite Launches 2nd Open Beta Test for PC MMORPG Ragnarok Zero: Global
of community events have also been prepared to celebrate the 2nd OBT:Complete pre-registration for both games to receive a Rare Poring Egg in Get Poring.Reach maximum level during the 2nd OBT to earn a Valhalla Pass for transferring nurtured Porings into the
More news about: Gravity Game Unite SDN. BHD.
Jul 06, 2026, 20:00 ET Gravity Game Unite startet den 2. offenen Beta-Test für das PC-MMORPG Ragnarok Zero: Global
zudem verschiedene Gemeinschaftsveranstaltungen vorbereitet:Schließen Sie die Vorregistrierung für beide Spiele ab, um ein Rare Poring Egg in Get Poring zu erhalten.Erreichen Sie während des 2. OBT die maximale Stufe, um einen Valhalla Pass zu erhalten, mit
More news about: Gravity Game Unite SDN. BHD.
Jul 06, 2026, 20:00 ET Gravity Game Unite lance la seconde bêta ouverte du MMORPG sur PC Ragnarok Zero: Global
également été organisées pour célébrer la seconde bêta ouverte :préinscrivez-vous pour les deux jeux afin de recevoir un Rare Poring Egg dans Get Poring.atteignez le niveau maximum lors de la seconde bêta ouverte pour obtenir un Valhalla Pass, qui vous permettra
More news about: Gravity Game Unite SDN. BHD.
Jul 06, 2026, 20:00 ET Gravity Game Unite triển khai giai đoạn Open Beta Test lần thứ 2 cho tựa game PC MMORPG Ragnarok Zero: Global
cộng đồng cũng đã được chuẩn bị để chào mừng đợt OBT lần thứ 2, bao gồm:Hoàn tất đăng ký trước cho cả hai trò chơi để nhận Rare Poring Egg trong Get Poring.Đạt cấp độ tối đa trong OBT lần thứ 2 để nhận Valhalla Pass khi chuyển các Poring đã được nuôi dưỡng
More news about: Gravity Game Unite SDN. BHD.
Jul 06, 2026, 17:58 ET Active Motif Announces Exclusive Global Distribution Agreement with Arima Genomics for Advanced 3D Genomics Solutions
enhancer-promoter interactions, and genome-wide regulatory mechanisms. These insights are increasingly important across cancer, neuroscience, developmental biology, rare disease research, and precision medicine. "This agreement strengthens Active Motif's position as a leading provider of integrated multiomics
More news about: Active Motif
Jul 06, 2026, 17:49 ET AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulatory Agency and Health Canada
July 6, 2026 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held clinical-stage specialty biopharmaceutical company focusing on rare genetic disorders with limited or no treatment options, today announced agreement with regulatory agencies in the U.S., U.K. and Canada on design for
More news about: AMO Pharma Limited
Jul 06, 2026, 17:44 ET Active Motif Announces Exclusive Global Distribution Agreement with Arima Genomics for Advanced 3D Genomics Solutions
enhancer-promoter interactions, and genome-wide regulatory mechanisms. These insights are increasingly important across cancer, neuroscience, developmental biology, rare disease research, and precision medicine. "This agreement strengthens Active Motif's position as a leading provider of integrated multiomics
More news about: Active Motif
Jul 06, 2026, 17:30 ET AMO Pharma Announces Update on Scientific Advice for Registrational Clinical Study of AMO-02 in Congenital Myotonic Dystrophy Type 1 Following Meetings with the U.S. Food and Drug Administration, the U.K. Medicines and Healthcare products Regulatory Agency and Health Canada
July 6, 2026 /PRNewswire/ -- AMO Pharma Limited ("AMO Pharma"), a privately held clinical-stage specialty biopharmaceutical company focusing on rare genetic disorders with limited or no treatment options, today announced agreement with regulatory agencies in the U.S., U.K. and Canada on design for
More news about: AMO Pharma Limited
Jul 06, 2026, 13:24 ET CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine
pharmacies to deliver personalized medicine in a safer and more efficient way," said Morten E. Iversen, partner at Sandwater. "CurifyLabs has built something rare — technology that combines clinical rigor with the speed and precision that busy pharmacy teams depend on. We are excited to support their rapid growth
More news about: CurifyLabs
Jul 06, 2026, 13:06 ET CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine
pharmacies to deliver personalized medicine in a safer and more efficient way," said Morten E. Iversen, partner at Sandwater. "CurifyLabs has built something rare — technology that combines clinical rigor with the speed and precision that busy pharmacy teams depend on. We are excited to support their rapid growth
More news about: CurifyLabs
Jul 06, 2026, 12:00 ET SIRUI Releases Three New Lightweight Full-Frame Cine Primes for Vision Prime Series: 15mm T1.6, 75mm T1.4, 150mm T4 (1.5x Macro)
design.From Grand Wide Shots to Ultra-Fine Macro DetailsThe 150mm T4 1.5x Macro stands out as a dual-purpose telephoto macro prime rare in lightweight cine optics. It delivers 1.5x reproduction ratio to capture intricate textures of tiny subjects—precision machinery, fabric texture,
More news about: SIRUI
Jul 06, 2026, 11:04 ET Air Appoints David Kensick as Chief Operating Officer to Scale Operations Amid Rapid National Security Growth
company on the 2026 index, an annual list of top venture-backed companies driving innovation in defense and dual-use technology."David brings a rare combination of corporate expertise, strategic vision, and deep military mission understanding that is essential for this next chapter of Air's expansion,"
More news about: Air
Jul 06, 2026, 10:31 ET Fuchs Endothelial Corneal Dystrophy Market Forecast Highlights Significant Growth During the Forecast Period (2026-2036), Owing to the Expanding Treatment Landscape and Increasing Patient Pool | DelveInsight
proliferation and migration. The development of TTHX1114 has been supported extensively by the National Institutes of Health (NIH) through its Therapeutics for Rare and Neglected Diseases Program. Positive results from the Phase II STORM trial demonstrated that TTHX1114 facilitated corneal regeneration and improved
More news about: DelveInsight Business Research, LLP
Jul 06, 2026, 09:00 ET The West Wants a Critical-Minerals Supply Chain Outside China. One Nasdaq Company Is Trying to Build a Piece of It in Greenland.
Tanbreez rare-earth project in southern Greenland, making it a direct geographic peer operating in the same jurisdiction as Greenland Mines. CRML offers a close comparison for how Greenland-based rare-earth assets are being advanced and financed amid Western supply-chain efforts.USA Rare Earth
More news about: Equity Insider
Jul 06, 2026, 09:00 ET Valpak Partners with Hallmark Channel to Offer Movie Walk-on Role Opportunity this July
"From Mailbox to Movie Set" sweepstakes winner will land an ultra-rare walk-on role in an upcoming original film from the beloved network ST. PETERSBURG, Fla., July 6, 2026 /PRNewswire/ -- Valpak,
More news about: Valpak
Jul 06, 2026, 08:34 ET Leica Store & Gallery New York Presents Growing Up Travelling by Jamie Johnson
Featuring photographs from her award-winning monograph and new unpublished works, Jamie Johnson's long-term documentary project offers a rare and intimate portrait of childhood within Ireland's Traveller community.NEW YORK, July
More news about: Leica Camera USA
Jul 06, 2026, 07:30 ET Rio Perdido Named the #5 Hotel in Costa Rica in Tripadvisor's 2026 Travelers' Choice Awards Best of the Best
acknowledges a philosophy rooted in caring for the land, preserving the surrounding rare tropical dwarf forest, and creating opportunities for travelers to reconnect with nature, family, and themselves.Set around a rare thermal river canyon and surrounded by one of the world's most endangered tropical
More news about: Rio Perdido
Jul 06, 2026, 07:00 ET Oak Ridge National Lab, Cleveland Clinic, and IBM Achieve First-Known Computations of Fusion Materials on a Quantum Computer
classical computers to scale when working alone. They are a fundamental step towards optimizing the production and extraction of tritium – an extremely rare material in nature that is necessary to produce fusion energy with most of the proposed machines. Ensuring adequate supplies of tritium has long been
More news about: IBM
Jul 06, 2026, 06:55 ET US Department of Energy Announces Selection of Core Natural Resources' Innovations Group to Pursue Critical Mineral and Material Extraction from Coal
The company plans to use the funding, once awarded, to develop a pilot-scale facility for the extraction of rare earth elements and critical materials from coal waste tailings sourced from Core's Pennsylvania Mining Complex."We applaud the Trump Administration
More news about: Core Natural Resources
Jul 06, 2026, 06:45 ET The Work Is Still Human: Global Knowledge Bets on Expert-Led Learning
Director at Enduring Ventures. "They don't come back because they have to. They come back because it works. Darren and his team have built something rare, and we're thrilled to keep building it with them."For customers, nothing changes: agreements, contacts, and day-to-day delivery all continue,
More news about: Global Knowledge
Jul 06, 2026, 06:00 ET FOR THE FIRST TIME IN A CENTURY, MAJOR PRESERVATION EFFORT UNDERWAY AT CHALMETTE, WAR OF 1812'S LAST BATTLE
the 250th anniversary of the Declaration of Independence, the powerful document that propelled the American Revolution; now, we are delighted by this rare opportunity to preserve a portion of the Battle of New Orleans, an engagement often hailed as the grand finale to America's 'Second War of Independence,'"
More news about: American Battlefield Trust